Skip to main content

Deleting fis downregulates virulence and effectively protects Pasteurella multocida infection in mice

Abstract

Pasteurella multocida (P. multocida) is an important pathogen causing various diseases in both domestic and wild animals. The factor for inversion stimulation (Fis) is a nucleoid-associated protein with diverse functions in various bacteria, which positively regulate the transcription of capsular glycosaminoglycan genes in P. multocida. However, the precise mechanistic understanding of how the fis regulate virulence of P. multocida remains largely unknown. In this study, we discovered that fis transcript levels of P. multocida CQ2, serotype A (PmCQ2) were significantly increased in vivo, and showed a positive correlation with the capsule and virulence of P. multocida. To further understand how the fis regulated P. multocida pathogenesis, a homologous recombination strategy was used to generate fis-deleted strain. Then, the growth velocity, virulence characteristics, immune/inflammatory responses, and the survival rates of challenged mice were determined. The findings revealed that the presence of fis promoted the growth, regulated synthesis of capsule and biofilm of PmCQ2, and helped to resist phagocytosis by macrophages. Notably, we firstly demonstrated that Fis determined whether P. multocida can use bound iron ion for its survival. Consequently, the loss of fis greatly restricted P. multocida pathogenicity, as evidenced by reducing tissue bacterial loads as well as inflammatory factors levels. Moreover, the fis deletion strain was endowed with strong cross immunoprotected properties against P. multocida serotype A and B. Thus, these results suggested the pathogenic role of fis in P. multocida and proposed that fis deletion strain could be used as an attenuated vaccine candidate against P. multocida of serotype A and B.

Peer Review reports

Background

P. multocida is an important veterinary pathogen that can cause various animal diseases, including hemorrhagic sepsis in ungulates, avian cholera in poultry, and atrophic rhinitis in pigs [1]. Various environmental stresses in animals lead to an increase of pasteurellosis caused by P. multocida, which results in significant economic losses. P. multocida can be classified into five capsular serotypes (A, B, D, E, F) based on capsular polysaccharides [2,3,4]. Each capsular serotypes produces a distinct capsular polysaccharide. The capsule is an important virulence factor required by the bacteria to survive. Although multiple genes, including phyA, phyB, hyaE, hyaD, hyaC, hyaB, hexD, hexC, hexB and hexA are involved in capsule biosynthesis and transport [5, 6], the transcription of the P. multocida capsular biosynthesis loci is mainly manipulated by the factor for inversion stimulation (fis) [7, 8]. The Fis of P. multocida is a nucleoid-associated protein comprising 99 amino acid residues and containing a helix-turn-helix DNA binding motif in residues 73–94 that is responsible for interactions with capsular DNA promoter regions, which positively regulate the transcription of capsular glycosaminoglycan genes [9]. The function of Fis is also different in various bacteria. The Fis represses curli synthesis [10], activates virF [11], produces the plasmid-borne toxin Pet [12], and negatively regulates the phase variation fimS switch of the type 1 pilus operon [13] in pathogenic Escherichia coli. In Pseudomonas aeruginosa, Fis manipulates type III secretion system by influencing the transcription of exsA [14]. In addition, the functions of Fis have been revealed in many other bacteria, including Salmonella enterica [15,16,17], Shigella flexneri [18], Vibrio cholera [19] and so on. However, few studies focused on the fis gene of P. multocida. In our previous study, fis of P. multocida was highly expressed in vivo as detected by transcriptomics. Based on previous studies, we hypothesized that fis is an important virulence factor of P. multocida.

In this study, we collated previous studies about the gene deletion strain of P. multocida by our group and confirmed the positive correlation between capsule and virulence. We first demonstrated that fis manipulated the intake of bound iron ion by regulating haemoglobin and/or haemin receptors in P. multocida. Our data supported that the fis gene of P. multocida regulated a variety of biological functions and affected bacterial virulence, and mice vaccinated with the live deleted fis strain (live Δfis strain) showed a strong cross-protection against P. multocida serotype A and serotype B.

Results

The correlation between bacterial capsules and virulence and construction of the fis deletion strain, complementary strain and overexpress strain.

In our previous transcriptomic study, we found that fis transcript levels in PmCQ2-infected mice were 11.98-fold higher than that in Martin medium. Then, qRT-PCR were used for validation and showed that fis transcript levels of PmCQ2 were significantly higher in mice than in the Martin medium (Fig. 1A). We collated previous studies [20,21,22,23,24] about gene deletion strains (8 strains, including PmCQ2 and 2 non-publicly available strains) of P. multocida by our group, and analyzed the correlation between their capsules and Lethal Dose 50% (LD50), and drew regression lines. The results showed that there was a significant negative correlation between capsule and LD50 (P < 0.01) (Fig. 1B).

Fig. 1
figure 1

The correlation between bacterial capsules and virulence and construction of the fis deletion strain (Δfis), complementary strain (C-fis) and overexpress strain (O-fis). A: Transcript levels of the fis gene (PmCQ2) in vitro and in vivo cultures. B: Correlation analysis between PmCQ2 capsule and LD50. C: PCR confirmation of PmCQ2, Δfis, C-fis and O-fis. M: DNA marker; Lanes 1, 4, 7 and 10: P. multocida detection by using species-specific primers KMT1-F/KMT1-R; Lanes 2, 5, 8 and 11: Plasmids detection by using primers KO-F/KO-R and OE-F/ OE-R. Lanes 3, 6, 9 and 12: fis gene detection by using primers Fis-UUF/Fis-DDR. D: fis gene transcripts measured by using qRT-PCR. E: fis gene overexpression measured by using Western Blot (PmCQ2-RS09000 protein as an internal reference). All data are expressed as mean ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001; ns means no significant

To investigate the role of Fis in P. multocida, we constructed a fis deletion strain (Δfis), a fis overexpressed strain (O-fis), and a fis gene complementary strain (C-fis) derived from Δfis. The construction process of plasmids and mutant strains is shown in Supplementary Fig. 1A and B. PCR validation showed that the fis gene was not in the chromosome of Δfis, but existed in a plasmid and chromosome of C-fis and O-fis (Fig. 1C). To further confirm the fis deletion, complementary and overexpressed strains, RT-PCR and Western Blot were conducted, respectively. RT-PCR showed that the fis gene transcripts only existed in PmCQ2, C-fis and O-fis, but not in Δfis (Fig. 1D). In addition, the fis gene transcription of O-fis was higher than that in other strains. Western Blot showed that the Fis with Myc-tag expressed in O-fis but not in the PmCQ2, suggesting the successful construction of O-fis strain (Fig. 1E).

The characteristics of Δfis

Compared with the wild-type strain PmCQ2, the fis deletion strain has smaller colonies at the same time of growth (Fig. 2A). In Martin broth medium, the wild-type strain PmCQ2 showed a typical growth curve, with a short lag phase (0–2 h), followed by a log phase during which major bacterial growth occurred (2–10 h) and then a stationary phase (10–12 h). In contrast, Δfis grew more slowly at 0–4 h, but the growth rate was reversed at 4–10 h. The OD value of Δfis were significantly lower than those of the wild-type strain between 4 and 8 h. The OD value of complementary strain C-fis and overexpressed strain O-fis were not significantly different form the parental strain (Fig. 2B). In LB broth medium, the logarithmic growth phase of P. multocida was between 2 and 6 h and reached peak in the 6th hour. But Δfis reached peak at the 8th hour and then entered a plateau phase (Fig. 2B). The Δfis has significantly reduced capsule content compared with PmCQ2, C-fis and O-fis (Fig. 2C). However, the biofilm content of Δfis was significantly higher than other strains (Fig. 2D). Furthermore, in the uptake assay for heme, Δfis was unable to uptake the additional bound iron added to the medium (Fig. 2E). According to report of Bosch et al. on haemoglobin receptors of P. multocida, we performed the analysis by RT-qPCR. Transcription of multiple binding haemoglobin receptors of Δfis was inhibited (Fig. 2F). The above results indicate that fis gene not only affect bacterial growth but also manipulated capsules biosynthesis. Importantly, Fis manipulate the uptake of bound iron by regulating the transcription of haemoglobin receptors.

Fig. 2
figure 2

The characteristics of Δfis. A Colony morphology of PmCQ2, Δfis, C-fis and O-fis cultured on Martin agar plates. B Growth curves of strains cultured in Martin broth and LB media at 37 °C with shaking at 200 rpm (The experiment was performed in triplicate). C Capsular polysaccharide production. D Quantification of biofilm production. E Heme binds iron uptake. F The transcription of haemoglobin receptors in PmCQ2 and Δfis, respectively. All data are expressed as mean ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001; ns means no significant

Pathogenicity analyses

A series of experiments confirmed changes in the virulence of Δfis. Mice were inoculated nasal drops with PmCQ2 and Δfis (4.0 × 105 CFU), respectively. The survival rate of mice infected with Δfis was significantly higher than those mice infected with PmCQ2 (Fig. 3A). To quantify the decrease of virulence in Δfis, 50% lethal dose (LD50) assays were conducted. The LD50 of Δfis via intraperitoneal route was 2.37 × 108 CFU, which was 2.37 × 108 fold higher than that of PmCQ2 (LD50 = 1 CFU) (Table 1). To further investigate whether the deletion of fis attenuates inflammatory cytokines levels and organs bacterial loads, a series of infection experiments was conducted. Compared to those mice infected with PmCQ2, the levels of TNF-α and IL-6 in the lung of Δfis infected mice were significantly lower, while C-fis and O-fis infected groups showed no significant changes. Additionally, there was no significant change in IL-1β levels between PmCQ2 and Δfis infection (Fig. 3B). The bacterial loads in the lungs of mice infected with Δfis were significantly lower than those infected with PmCQ2 and C-fis and O-fis (Fig. 3C). In vitro, bacterial resistance to adherent and phagocytosis by mouse macrophages was explored. The results indicated that the deletion of fis did not decrease anti-macrophage adhesion to P. multocida; however, there was a significant reduction in anti-macrophage phagocytosis (Fig. 3D).

Fig. 3
figure 3

Pathogenicity analyses. A: Survival rates of mice nasal drop infected with PmCQ2 and Δfis, respectively, n = 8 mice/group. B: Concentrations of IL-1β, IL-6, and TNF-α in the lung of mice after infection. C: Bacterial loads of lungs, livers, and spleens with PmCQ2, Δfis, C-fis and O-fis in mice. D: Macrophage engulfment of bacteria and proportion of adherent phagocytic bacteria. All data are expressed as mean ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001; ns means no significant

Table 1 Determination of the LD50 in Δfis

Cross-protection against P. multocida serotypes induced by live Δfis

To explore the effect of fis deletion on antibody, the serum IgG titers of the mice immunized with inactivated Δfis and live Δfis were measured by using ELISA. Scheme of immunization and infection was performed as described in Fig. 4A. The antibody titers of live Δfis were significantly higher than inactivated Δfis (Fig. 4B). Both inactivated Δfis and live Δfis provided 100% protection against PmCQ2 (Supplementary Fig. 2 Left A and Fig. 4C). Only live Δfis induced robust immune protection against PmB (90%), whereas inactivated Δfis showed a lower level of protection (30%) (Fig. 4D and Supplementary Fig. 2 Right). Then, mice were immunized with live Δfis, and the monitoring procedure for serum IgG antibody titers was performed according to Fig. 4F. The serum IgG antibody titers against PmCQ2 (serotype A) and PmB (serotype B) peaked at high levels 30 days after immunization with live Δfis and remained stable until 90 days after the conclusion of the study, indicating that live Δfis consistently stimulated the host to secrete sufficient antibodies to against P. multocida. (Fig. 4E).

Fig. 4
figure 4

Cross-protection against P. multocida serotypes induced by live Δfis. Scheme of immunization and infection A. Serum IgG antibody titers B. The survival rates of mice subcutaneously immunized with live Δfis and PBS emulsifier and challenged with PmCQ2 (C) and PmB (D), respectively. Serum IgG antibody titers of PmCQ2 and PmB were monitored 7–90 days after immunization with live Δfis E. Scheme of immunization and antibody titer monitoring F. All data are expressed as mean ± SD. * P < 0.05; ** P < 0.01; *** P < 0.001; ns means no significant

Discussion

Transcription factors (TF) are essential in regulating bacterial gene expression. As one of TF [25], Fis can enhance the synthesis of transfer and ribosomal RNAs. Interestingly, Fis is ubiquitous, but the function varies among bacteria [25]. In P. multocida, Fis regulates bacterial capsule synthesis [8]. Capsule is an important virulence factor of P. multocida [26]. The synthesis and transport capsule for P. multocida require a variety of proteins to act synergistically [5, 6]. In this study, we observed that deletion of fis gene in P. multocida resulted in smaller bacterial colonies, lower growth rate, lower capsule and higher biofilm than the wild strain. These results further confirmed that fis gene manipulated the growth and capsule synthesis of P. multocida. The transcription of the fis directly affects the virulence of P. multocida, as indicated by the survival rate of mice infected with Δfis (Fig. 3A).

Previously, transcriptomic analysis of fis natural mutant L28S of P. multocida was reported [8]. Thirty-one genes were identified as significantly downregulated and eleven genes as significantly up-regulated in the fis mutant strain. Among them, several capsule-associated genes, iron regulatory genes, cross-serotype protective proteins encoded genes, and other virulence genes were downregulated. However, the Fis protein is predicted to contain 4 functional domains, single point mutations may not be sufficient to characterize the function of the whole fis, therefore we deleted the whole fis from the genome for more precise functional investigation. Our results also showed that the fis deletion strain utilized free iron ions in Martin broth medium, but was unable to utilize bound heme directly and showed a significant reduction in virulence. These results are consistent with our previous results [27] and the transcriptome results of Steen et al. [8]. In addition to lspB 2 (Hemolysin accessory protein), Pm1078 (Hemin binding receptor) and exbB (Iron regulated virulence protein) mentioned in the results of Steen et al. [8] We also found that Fis manipulate the uptake of bound iron by other regulating the transcription of haemoglobin receptors, including Pm040, Pm236, Pm300, Pm576, Pm592, Pm741, Pm1081, Pm1282 and Pm1428. In subsequent experiments, we expressed Fis with Myc-tag in the wild strains PmCQ2 to attempt to pull down the related proteins, but were unsuccessful, and the specific molecular mechanism still needs to be further explored.

To clarify the contribution of fis to the virulence of P. multocida, a fis mutant strain was evaluated in mice. In our previous work, we found that inflammatory storm contributed to Pm-induced host death [20, 21]. Here, mice infected with fis deletion strain showed significantly lower TNF-α and IL-6 expression in the lung compared to mice infected with wild type strain, indicating fis deletion reduced host inflammatory reactions. Interestingly, the IL-1β secretion was not reduced by the absence of the fis gene. This result suggested that IL-1β secretion was not only mediated by bacterial capsule. Moreover, mice infected with fis deletion strain exhibited lower bacterial loads in organs. The fis deletion strain was also more phagocytosed by macrophages in vitro. Thus, the fis deletion strain tended to be clear by the host immune system. In summary, the fis deletion strain exhibited less virulence and a milder inflammatory response in mice.

Pasteurella types A and B are the most harmful types to the beef cattle industry, and it is particularly important to develop cross-protection vaccines. Some commercial vaccines of P. multocida protect bovine against infection with homologous serotypes [28], but the lack of a universal vaccine showed strong cross-protection against P. multocida infection. In the present study, the live Δfis not only stimulates the high levels of antibody, but also produces immune protection against P. multocida type B. The LD50 of Δfis was increased by 2.37 × 108 fold, and the virulence reduction was very significant, which be developed as an attenuated vaccine candidate strain. In addition, the general virulence was decreased in Δfis, but the expression of some virulence-related genes such as pm1819 and pm1820, which encode proteins with similarity to the Salmonella SrfB and SrfC proteins, were up-regulated [8]. The fis deletion strain lacks capsule, which is more likely to be phagocytosed by macrophages to present antigen and moderately stimulate the secretion of inflammatory cytokines. These may all contribute to the ability of Δfis to protect against serotype A and B. Although the antibody titer against Pasteurella type B was high in mice immunized with inactivated Δfis, it did not protect mice from Pasteurella type B infection. This is due to the decreased expression of several immune proteins that can stimulate cross-serotype protective immunity against P. multocida infection after fis deletion, such as PlpE [8]. It is worth mentioning that, in our previous study, one P. multocida mutant with a substantial deletion of a DNA fragment encompassing six genes (PmCQ2Δ4555–4580) exhibited notable attenuation of virulence and displayed remarkable cross-protection. The fis is one of them [27].

Conclusion

The fis regulated capsule production, biofilm formation, and virulence in P. multocida. Our study firstly demonstrated that fis manipulated the intake of bound iron ion, by regulating multiple haemoglobin receptors in P. multocida, and the fis deletion strain can be used as an attenuated vaccine candidate against P. multocida of A and B serotypes.

Methods

Bacterial strains and growth conditions

The highly virulent bovine P. multocida capsular type A CQ2 (PmCQ2, GenBank accession number: No. CP033599) was isolated from a lung of calf with pneumonia in Chongqing, China [29]. Bovine P. multocida capsular serotype B strain B (B: L2, PmB) was purchased from the China Institute of Veterinary Drug Control [21]. PmCQ2 and PmB was streaked on Martin agar plate (Qingdao Hope Bio-Technology Co., Ltd., Qingdao, China) and incubated for 24 h at 37°C. Single colony was inoculated into 5 mL Martin broth and cultured for 12 h at 37°C with shaking at 220 rpm.

Construction of plasmids

To enhance the knockout efficiency of the knockout plasmid (pUC19oriTSKanR) [30], pUC19oriTSKanRNgAgo was constructed as described by Fu et al. [31]. A NgAgo gene (GenBank ID: KU899087.1) and a ribosome binding sequence (rbs) were biosynthesis by BGI (BGI, Shenzhen, China) and then inserted in upstream of the kanamycin resistance gene (KanR) in the pUC19oriTSKanR to generate the pUC19oriTSKanRNgAgo plasmid (The seamless cloning kit was provided by Hanbio Biotechnology, China) with the pUC19oriTSKanR-F/R and NgAgo-rbs-F/R primers (Supplementary Table 1).

Construction of the knockout plasmid pUC19oriTSKanRNgAgo-Δfis. A 335 bp upstream and 334bp downstream homology arm of fis gene was amplified by using PmCQ2 genomic DNA as a template with the primers Fis-UF/UR and Fis-DF/DR. The upstream and downstream homology arms were combined into fis homology arms by fusion PCR. Next, the PCR product was inserted into the HindIII and BamHI sites of temperature-sensitive knockout plasmid pUC19oriTSKanRNgAgo to generate the plasmid pUC19oriTSKanRNgAgo-Δfis.

Construction of the overexpress plasmid pUC19oriTSKanR-fis. Briefly, a 349 bp segment containing initiation codon of fis gene, HA and Myc tag was amplified by using PmCQ2 genomic DNA as a template with the primers fis-F/R and then replaced NgAgo in upstream of the rbs in the pUC19oriTSKanRNgAgo to generate the pUC19oriTSKanR-fis plasmid with the pUC19oriTSKanR-fis-F/R primers.

Construction of the knock-in plasmid pUC19oriTSKanR-cfis. A 1144 bp contained fis gene and the upstream and downstream homology arms was amplified by using PmCQ2 genomic DNA as a template with the primers Fis-UF/DR. Next, the PCR product was inserted into the HindIII and BamHI sites of temperature-sensitive knockout plasmid pUC19oriTSKanRNgAgo to generate the plasmid pUC19oriTSKanRNgAgo-cfis. Construction of plasmids are shown in Supplementary Fig. 1A.

Construction of mutant strain

The knockout/overexpress plasmid and knock-in plasmid were transferred into PmCQ2 and Δfis by electroporation (2500 V, 5 ms), respectively. The strains with plasmids were screened on Martin agar plates with kanamycin (100 μg/mL) at 30 °C and verified by PCR with primers KO-F/R, EO-F/R and Fis-UUF/DDR. Subsequently, 100 μL Δfis, transformants was spread onto Martin agar plates and grown at 42 °C for 16 h to allow plasmid resolution. KMT1-F/R primers were used to identify P. multocida [32, 33]. Primers sequences are listed in Supplementary Table 1, strains and plasmids are listed in Supplementary Table 2.

Real-time-quantitative -PCR (RT-qPCR)

Total RNA of the bacterial samples was extracted by RNA Kit (ABclonal, China) based on the manufacturer’s instructions. Next, extracted RNA was reverse transcribed to cDNA by Reverse Transcription Master Mix (ABclonal, China) according to manufacturer’s recommendations. Then, RT-qPCR was performed via SYBR Green on a CFX96 instrument (Bio-Rad). Relative expression of genes was calculated using the 2−ΔΔCt method with 16S as reference. Primer sequences for RT-qPCR are listed in Supplementary Table 3.

Western blot

O-fis was collected by centrifugation in the logarithmic phase. The pellets were washed 3 times and re-suspended with sterile PBS (pH 7.4). After sonication of the resuspended bacterial suspension, protein loading buffer was added and completely denatured by a boiling water bath for 10 min. Fis proteins were detected by using 15% SDS-PAGE and blotted electrophoretically onto a polyvinylidene difluoride (PVDF) membrane. The membrane was incubated with Myc tag antibody (1:2500; Huabio, China) and horseradish peroxidase-conjugated goat anti-rabbit IgG antibodies (1:20,000; Sigma). An Enhanced Chemiluminescent reagent (Pierce; Thermo) was applied for a chromogenic reaction. Proteins were visualized using a LTQ Mass Spectrometer (Shanghai Applied Protein Technology Co. Ltd., Shanghai, China).

Determination of bacterial growth curve

Logarithmic bacterial cells (10 μL, 1.0 × 107 CFU) were added into 5 mL fresh sterile Martin broth and LB broth liquid, then incubated at 37 °C with shaking at 220 rpm, and OD600 values of the bacterial cultures were determined at every 2 h.

Heme iron uptake

To explore the effect of Fis proteins on heme uptake, 250 μM bipyridine were used to chelate free iron ions in the Martin broth. Meanwhile, 20 μM heme and 400 μM ferrous chloride were added to Martin broth treated with bipyridine. PmCQ2, Δfis, C-fis, and O-fis was inoculated into treated Martin broth and cultured for 12 h at 37°C with shaking at 220 rpm. Samples were measured optical density at 600 nm (OD600) every 2 h to plot the growth curve. According to report of Bosch et al. on haemoglobin receptors [34] of P. multocida, we performed the analysis by RT-qPCR.

Quantification of hyaluronic acid in the capsule of bacteria

Bacteria were grown in 100 mL Martin broth and incubated at 37 °C with 220 rpm for 8 h to logarithmic phase. The supernatant was removed after centrifugation at 7600 g for 10 min, washed twice with PBS and resuspended. Next, incubation for 1h at 42 °C, the centrifuged supernatant was used to determine the capsule content. To be specific, after the capsule staining solution (0.2 mg/mL Stain all, 0.06% glacial acetic acid in 50% formamide) was mixed with the sample or standard substance at a ratio of 1: 9, the absorbance of OD630 was measured by a microplate reader. The standard curve was drawn by setting the standard substance gradient and calculate the capsule content.

Biofilm assay

Biofilm assay was conducted based on the method described by Petruzzi et al. [35], 100ul (1.0 × 107 CFU) of bacteria were inoculated in 96-well cell culture plates and incubated for 48 h at 37 ℃. The bacterial cultures of each well were drawn off, methanol (100 μL/well) was added into each well and fixed for 30 min, washed with PBS for 3 times and dried for 1 h. Then 0.1% crystal violet staining solution (100 μL/well) was added into each well and stained at 37 °C for 15 min, discarded crystal violet solution in each well and washed with PBS for 3 times and dried at room temperature. Finally, 33% glacial acetic acid solution was added and measured at OD590 by microplate reader.

Mice and ethics statement

Kunming mice (Female, 25–30 g) were purchased from the SPF (Sibeifu Biotechnology Co., Ltd., Beijing) and housed in individually ventilated pathogen-free cages (temperature at 20–30 °C, relative humidity at 50–60%, and lighting cycle at 12 h/day) with free access to food and water. The mice were acclimatized for 4 days after arrival to the laboratory before starting the experiments. All animal experiments were carried out with approval from the Animal Ethics and Research Committee of Southwest University (SWU_LAC2023120053), Chongqing, China. After finishing the animal experiments, the mice were anaesthetized with 1.5% pentobarbital sodium and then euthanized for blood and tissue collection.

Pathogenicity of mutant strain

To determine the pathogenicity of the PmCQ2 and Δfis. Kunming mice (n = 8) were infected by nasal drop infection with PmCQ2 and Δfis at a dose of 4 × 105 CFU in 10 μL, and the numbers of mice used for each strain detection were equal. Mice were monitored for 7 days to determine the survival curves, mice showing severe clinical signs (e.g., depression, accelerated breath, cough, hairiness, and lethargy) were considered moribund and were humanely killed.

Fifty (50%) lethal dose LD50 measurements in mice

To determine the impact of Fis protein on PmCQ2 virulence, 100 female KM mice (7/8-week-old) were randomly divided into 8 groups (n = 8). Δfis groups (5 groups) of mice were infected intraperitoneal with 100 μL of various doses Δfis (1.25 × 108, 2.5 × 108, 5.0 × 108, 1.0 × 109, and 2.0 × 109 CFU), respectively. Mice were monitored for 7 days to determine the survival curves, and mice were humanely euthanized with severe clinical signs. Then, the numbers of survived mice in each group were recorded, and the Lethal Dose 50% (LD50) was calculated with the method of Bliss [36].

Quantitation of P. multocida associated with macrophage

Peritoneal macrophages were isolated from mice as previously described [20, 20]. Peritoneal macrophages were cultured in RPMI 1640 medium with 10% heat-inactivated fetal bovine serum and counted with a hemocytometer, and then incubated overnight at 37 °C with 5% CO2 in 48-well microplates at a density of 1.0 × 106 cells/well. The macrophages challenged with P. multocida at a multiplicity of infection (MOI) of 1 for 6 h. Cells were washed three times with chilled PBS (Total number of adhered and phagocytosed P. multocida), and the cells of another 48-well microplate were treated with 1% penicillin–streptomycin for 30 min and washed 3 times with PBS (number of phagocytosed P. multocida). The cell lysates were diluted with PBS and grown on Martin’s agar plates at 37°C for 24 h to determine the number of P. multocida. The number of adhered P. multocida was equal to the total number of adhered and phagocytosed P. multocida minus the number of phagocytosed P. multocida.

Bacterial colonization and lung inflammatory factor detection

Mice (n = 4 / group) were intraperitoneally infected with 2 × 105 CFU of PmCQ2, Δfis, C-fis, and O-fis strains for 14 h, respectively. And mice were euthanized for collection of lung, liver and spleen tissues to measure the bacterial loads (n = 4 / group) [37]. The lung inflammatory cytokines (TNF-α, IL-1β and IL-6) were detected by ELISA kits (Invitrogen, USA).

Immunization and challenge trial

To determine immune protection of live Δfis and inactivated Δfis, 80 female KM mice were randomly divided into 8 groups (n = 10/group). Mice were subcutaneous injected with inactivated Δfis (2 groups), PBS emulsifier (2 groups), live Δfis (2 groups), and PBS (2 groups), respectively. Mice received booster immunization 14 days after the first immunization. Fourteen days later, mice were intramuscularly infected with PmCQ2 (2.0 × 107 CFU, 4 groups) and PmB (1.0 × 107 CFU, 4 groups). The specific operation and dose of immunity and infection is shown in the Fig. 4A and Table 2. The mice were monitored for 7 days after challenge, which showing severe clinical signs were considered moribund and were humanely euthanized, and the numbers of survived mice in each group were recorded.

Table 2 Scheme of immunization and infection

Statistical analysis

Data about characteristics of Δfis are expressed as the mean ± standard deviation (SD) from three independent experiments (n = 3), and data about pathogenicity analyses are expressed as the mean ± standard deviation (SD) from four independent experiments (n = 4). All statistical analyses were performed using GraphPad Prism software. The survival rates of the mice were evaluated using Kaplan‒Meier analysis (Prism 6.0). All the other data between two groups were evaluated using unpaired, two-tailed Student’s t test (Prism 6.0). Significant differences were considered as p < 0.05 (∗ p < 0.05, ∗ ∗ p < 0.01, ∗ ∗ ∗ p < 0.001).

Data availability

The data used to support the findings of this study are available from the corresponding author upon reasonable request.

Abbreviations

Pm:

Pasteurella multocida

LD50:

Median lethal dose

CFU:

Colony-forming units

PCR:

Polymerase chain reaction

RT-qPCR:

Real-time-quantitative-PCR

PBS:

Phosphate buffer saline

TNF-α:

Tumor necrosis factor α

IL-6:

Interleukin-6

IL-1β:

Interleukin-1 β

References

  1. Wilson BA, Ho M. Pasteurella multocida: from zoonosis to cellular microbiology. Clin Microbiol Rev. 2013;26(3):631–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Carter GR. Studies on Pasteurella multocida. I. A hemagglutination test for the identification of serological types. Am J Vet Res. 1955;16(60):481–484.

  3. Dabo SM, Taylor JD, Confer AW. Pasteurella multocida and bovine respiratory disease. Anim Health Res Rev. 2007;8(2):129–50.

    Article  CAS  PubMed  Google Scholar 

  4. DeAngelis PL, Gunay NS, Toida T, Mao WJ, Linhardt RJ. Identification of the capsular polysaccharides of Type D and F Pasteurella multocida as unmodified heparin and chondroitin, respectively. Carbohydr Res. 2002;337(17):1547–52.

    Article  CAS  PubMed  Google Scholar 

  5. Chung JY, Zhang Y, Adler B. The capsule biosynthetic locus of Pasteurella multocida A:1. FEMS Microbiol Lett. 1998;166(2):289–96.

    Article  CAS  PubMed  Google Scholar 

  6. Guan L, Xue Y, Ding W, Zhao Z. Biosynthesis and regulation mechanisms of the Pasteurella multocida capsule. Res Vet Sci. 2019;127:82–90.

    Article  CAS  PubMed  Google Scholar 

  7. Dorman CJ, Deighan P. Regulation of gene expression by histone-like proteins in bacteria. Curr Opin Genet Dev. 2003;13(2):179–84.

    Article  CAS  PubMed  Google Scholar 

  8. Steen JA, Steen JA, Harrison P, Seemann T, Wilkie I, Harper M, Adler B, Boyce JD. Fis is essential for capsule production in Pasteurella multocida and regulates expression of other important virulence factors. PLoS Pathog. 2010;6(2):e1000750.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Bagchi A. Structural characterization of Fis - A transcriptional regulator from pathogenic Pasteurella multocida essential for expression of virulence factors. Gene. 2015;554(2):249–53.

    Article  CAS  PubMed  Google Scholar 

  10. Saldaña Z, Xicohtencatl-Cortes J, Avelino F, Phillips AD, Kaper JB, Puente JL, Girón JA. Synergistic role of curli and cellulose in cell adherence and biofilm formation of attaching and effacing Escherichia coli and identification of Fis as a negative regulator of curli. Environ Microbiol. 2009;11(4):992–1006.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Falconi M, Prosseda G, Giangrossi M, Beghetto E, Colonna B. Involvement of FIS in the H-NS-mediated regulation of virF gene of Shigella and enteroinvasive Escherichia coli. Mol Microbiol. 2001;42(2):439–52.

    Article  CAS  PubMed  Google Scholar 

  12. Rossiter AE, Browning DF, Leyton DL, Johnson MD, Godfrey RE, Wardius CA, Desvaux M, Cunningham AF, Ruiz-Perez F, Nataro JP, Busby SJ, Henderson IR. Transcription of the plasmid-encoded toxin gene from enteroaggregative Escherichia coli is regulated by a novel co-activation mechanism involving CRP and Fis. Mol Microbiol. 2011;81(1):179–91.

    Article  CAS  PubMed  Google Scholar 

  13. Saldaña-Ahuactzi Z, Soria-Bustos J, Martínez-Santos VI, Yañez-Santos JA, Martínez-Laguna Y, Cedillo-Ramirez ML, Puente JL, Girón JA. The Fis Nucleoid Protein Negatively Regulates the Phase Variation fimS Switch of the Type 1 Pilus Operon in Enteropathogenic Escherichia coli. Front Microbiol. 2022;13:882563.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Deng X, Li M, Pan X, Zheng R, Liu C, Chen F, Liu X, Cheng Z, Jin S, Wu W. Fis Regulates Type III Secretion System by Influencing the Transcription of exsA in Pseudomonas aeruginosa Strain PA14. Front Microbiol. 2017;8:669.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Dillon SC, Dorman CJ. Bacterial nucleoid-associated proteins, nucleoid structure and gene expression. Nat Rev Microbiol. 2010;8(3):185–95.

    Article  CAS  PubMed  Google Scholar 

  16. Cróinín T, Carroll RK, Kelly A, Dorman CJ. Roles for DNA supercoiling and the Fis protein in modulating expression of virulence genes during intracellular growth of Salmonella enterica serovar Typhimurium. Mol Microbiol. 2006;62(3):869–82.

    Article  Google Scholar 

  17. Kelly A, Goldberg MD, Carroll RK, Danino V, Hinton JCD, Dorman CJ. A global role for Fis in the transcriptional control of metabolism and type III secretion in Salmonella enterica serovar Typhimurium. Microbiology (Reading). 2004;150(Pt 7):2037–53.

    Article  CAS  PubMed  Google Scholar 

  18. Steinmann R, Dersch P. Thermosensing to adjust bacterial virulence in a fluctuating environment. Future Microbiol. 2013;8(1):85–105.

    Article  CAS  PubMed  Google Scholar 

  19. Lenz DH, Bassler BL. The small nucleoid protein Fis is involved in Vibrio cholerae quorum sensing. Mol Microbiol. 2007;63(3):859–71.

    Article  CAS  PubMed  Google Scholar 

  20. He F, Qin X, Xu N, Li P, Wu X, Duan L, Du Y, Fang R, Hardwidge PR, Li N, Peng Y. Pasteurella multocida Pm0442 Affects Virulence Gene Expression and Targets TLR2 to Induce Inflammatory Responses. Front Microbiol. 2020;11:1972.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Yang Y, Hu P, Gao L, Yuan X, Hardwidge PR, Li T, Li P, He F, Peng Y, Li N. Deleting qseC downregulates virulence and promotes cross-protection in Pasteurella multocida. Vet Res. 2021;52(1):140.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. He F, Zhao Z, Wu X, Duan L, Li N, Fang R, Li P, Peng Y. Transcriptomic Analysis of High- and Low-Virulence Bovine Pasteurella multocida in vitro and in vivo. Front Vet Sci. 2021;8: 616774.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Yang X, Hu P, Huang J, Gao L, Lv R, Qiu Y, He F, Peng Y, Li N. Construction and cross-protection of marker-free infC mutant of bovine Pasteurella multocida type A Chin. J Vet Sci. 2024;44(9):1930–9.

    Google Scholar 

  24. Yang Y, Xie L, Hu P, Gao L, Yuan X, Li P, Peng Y, Li N. Construction of bovine Pasteurella multocida type A hyaD mutant and its cross-protection analysis in mice. Acta Vet Zootech Sin. 2022;53(10):3582–97.

    Google Scholar 

  25. Duprey A, Reverchon S, Nasser W. Bacterial virulence and Fis: adapting regulatory networks to the host environment. Trends Microbiol. 2014;22(2):92–9.

    Article  CAS  PubMed  Google Scholar 

  26. Shirzad Aski H, Tabatabaei M. Occurrence of virulence-associated genes in Pasteurella multocida isolates obtained from different hosts. Microb Pathog. 2016;96:52–7.

    Article  CAS  PubMed  Google Scholar 

  27. He F, Xiong P, Zhang H, Yang L, Qiu Y, Li P, Zhao G, Li N, Peng Y. Attenuated vaccine PmCQ2Δ4555-4580 effectively protects mice against Pasteurella multocida infection. BMC Vet Res. 2024;20(1):94.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Al-Hasani K, Boyce J, McCarl VP, Bottomley S, Wilkie I, Adler B. Identification of novel immunogens in Pasteurella multocida. Microb Cell Fact. 2007;6:3.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Du H, Fang R, Pan T, Li T, Li N, He Q, Wu R, Peng Y, Zhou Z. Comparative Genomics Analysis of Two Different Virulent Bovine Pasteurella multocida Isolates. Int J Genomics. 2016;2016:4512493.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Li N, Feng T, Wang Y, Li P, Yin Y, Zhao Z, Hardwidge PR, Peng Y, He F. A single point mutation in the hyaC gene affects Pasteurella multocida serovar A capsule production and virulence. Microb Pathog. 2021;159:105145.

    Article  CAS  PubMed  Google Scholar 

  31. Fu L, Xie C, Jin Z, Tu Z, Han L, Jin M, Xiang Y, Zhang A. The prokaryotic Argonaute proteins enhance homology sequence-directed recombination in bacteria. Nucleic Acids Res. 2019;47(7):3568–79.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Townsend KM, Boyce JD, Chung JY, Frost AJ, Adler B. Genetic organization of Pasteurella multocida cap Loci and development of a multiplex capsular PCR typing system [published correction appears in J Clin Microbiol 2001 Jun; 39(6):2378]. J Clin Microbiol. 2001;39(3):924–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Townsend KM, Frost AJ, Lee CW, Papadimitriou JM, Dawkins HJ. Development of PCR assays for species- and type-specific identification of Pasteurella multocida isolates. J Clin Microbiol. 1998;36(4):1096–100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Bosch M, Garrido ME, Pérez de Rozas AM, Badiola I, Barbé J, Llagostera M. Pasteurella multocida contains multiple immunogenic haemin- and haemoglobin-binding proteins. Vet Microbiol. 2004;99(2):103–12.

  35. Petruzzi B, Briggs RE, Tatum FM, Swords WE, De Castro C, Molinaro A, Inzana TJ. Capsular Polysaccharide Interferes with Biofilm Formation by Pasteurella multocida Serogroup A. [published correction appears in mBio. 2018;9(1):e00176–18.

  36. Liu L, Yu H, Wu H, Yang X, Pan Y, Chen Y, Wang K, Wang W, Zhang W, Jin Y, Zhang C, Jiang A, Xia C. Toxic proteins from Croton tiglium L. exert a proinflammatory effect by inducing release of proinflammatory cytokines and activating the p38-MAPK signaling pathway. Mol Med Rep. 2017;16(1):631–638.

  37. He F, Yin Z, Wu C, Xia Y, Wu M, Li P, Zhang H, Yin Y, Li N, Zhu G, Ren W, Peng Y. l-Serine Lowers the Inflammatory Responses during Pasteurella multocida Infection. Infect Immun. 2019;87(12):e00677-e719.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank Beijing Genomics Institute (BGI, Shenzhen, China) for the technical assistance.

Funding

This work was supported by the earmarked fund of the China Agriculture Research System (Grant #: Beef/Yak Cattle, CARS-37 to YP).

Author information

Authors and Affiliations

Authors

Contributions

Y.P. and N.L. designed the experiment; Z.W., S.L., M.X., L.L., Z.L., X.Z., and G.Z. conducted the experiment; Z.W., S.L., L.L., Z.L., and X.Z. performed data analysis and figures; Z.W., G.Z., S.L.and M.X. drafted the manuscript; Y.P. and N.L. revised and approved the final manuscript; all authors reviewed the manuscript.

Corresponding author

Correspondence to Yuanyi Peng.

Ethics declarations

Ethics approval and consent to participate

Ethics approval and consent to participate all experimental protocols were approved by Animal Ethics and Research Committee of Southwest University [SWU_LAC2023120053], Chongqing, China. All methods were reported in accordance with ARRIVE guidelines (https://arriveguidelines.org) for the reporting of animal experiments. All methods were strictly performed in accordance with the relevant guidelines and regulations to minimize animal sufferings.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, Z., Liu, S., Xie, M. et al. Deleting fis downregulates virulence and effectively protects Pasteurella multocida infection in mice. BMC Vet Res 21, 323 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12917-025-04769-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12917-025-04769-x

Keywords